オミクロン株対応ワクチンの一部変更承認について｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_35190.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
オミクロン株対応ワクチンの一部変更承認について｜厚生労働省
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page announces the partial approval of Spikevax (Moderna) by Japan's Ministry of Health, Labour and Welfare on September 12, 2023. The approval adds a monovalent vaccine containing mRNA encoding the spike protein of the Omicron XBB.1.5 variant. For booster immunization, the dose is 0.5 mL for those 12 years and older, and 0.25 mL for those aged 6 to under 12 years. Vaccination can be administered at least 3 months after the previous SARS-CoV-2 vaccine dose.
